Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Bell

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Nature Medicine|April 21, 2015
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activityCarolina S Ilkow, Monique Marguerie, Cory Batenchuk, et al.
Cancer Cell|July 28, 2015
VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus InfectionRozanne Arulanandam, Cory Batenchuk, Fernando A Angarita, et al.
The Journal of Experimental Medicine|June 13, 2024
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathwayJonathan J Hodgins, John Abou-Hamad, Colin Edward O'Dwyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screenZaid Taha, Rozanne Arulanandam, Glib Maznyi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infectionStephen Boulton, Joanna Poutou, Nikolas T Martin, et al.
ACS Infectious Diseases|October 18, 2021
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of ConcernMadalina Elena Carter-Timofte, Rozanne Arulanandam, Naziia Kurmasheva, et al.
Nature Biomedical Engineering|November 28, 2024
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic virusesReza Rezaei, Stephen Boulton, Mahsa Ahmadi, et al.
Nature Communications|April 8, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapyMarie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi, et al.
Frontiers in Immunology|January 5, 2023
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignanciesNatasha Kekre, Kevin A Hay, John R Webb, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Nature Medicine|April 21, 2015
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activityCarolina S Ilkow, Monique Marguerie, Cory Batenchuk, et al.
Cancer Cell|July 28, 2015
VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus InfectionRozanne Arulanandam, Cory Batenchuk, Fernando A Angarita, et al.
The Journal of Experimental Medicine|June 13, 2024
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathwayJonathan J Hodgins, John Abou-Hamad, Colin Edward O'Dwyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screenZaid Taha, Rozanne Arulanandam, Glib Maznyi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infectionStephen Boulton, Joanna Poutou, Nikolas T Martin, et al.
ACS Infectious Diseases|October 18, 2021
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of ConcernMadalina Elena Carter-Timofte, Rozanne Arulanandam, Naziia Kurmasheva, et al.
Nature Biomedical Engineering|November 28, 2024
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic virusesReza Rezaei, Stephen Boulton, Mahsa Ahmadi, et al.
Nature Communications|April 8, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapyMarie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi, et al.
Frontiers in Immunology|January 5, 2023
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignanciesNatasha Kekre, Kevin A Hay, John R Webb, et al.
Pageof 20